Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel cobalt-catalyzed method for 3-thio-1-enose compounds offering high regioselectivity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN114940657B reveals metal-free light-induced amidine synthesis. Enables cost reduction and high-purity pharmaceutical intermediates manufacturing with scalable green chemistry.
Novel Pd-catalyzed route for trifluoroacetyl indoline. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111675662A reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for API manufacturing.
Patent CN117384157B details a green FeCl3-catalyzed route for Camelinine B. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115286553B reveals efficient indole synthesis via nickel catalysis. Reduces steps and cost for pharmaceutical intermediates manufacturing supply chain reliability.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)one derivatives, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN106349249A enables room temperature synthesis of norcantharidin derivatives with high yield and reduced solvent toxicity for pharmaceutical intermediates.
Patent CN102432523B reveals a copper-catalyzed route for high-purity indole derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112694430B reveals a safe palladium-catalyzed route using solid CO sources, offering significant cost reduction in API manufacturing and reliable supply chains.
Patent CN114516880B details copper-catalyzed synthesis offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel indolocyclopentanes synthesis via chiral phosphoric acid. High yield, mild conditions. Reliable pharmaceutical intermediates supplier for anticancer drug development.
Novel Pd-catalyzed pathway reduces costs and enhances supply chain reliability for high-purity chroman amide pharmaceutical intermediates manufacturing globally.
Patent CN112209947A details a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel CuCl catalyzed method offers cost reduction and scalable production for high purity pharmaceutical intermediates without anhydrous conditions.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering cost reduction in API manufacturing and scalable production.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand synthesis enabling high-yield asymmetric difunctionalization for cost-effective API manufacturing.
Patent CN110467556B reveals a mild Ni(II) catalytic route for 3-substituted isoindolinones, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel palladium-catalyzed method offers high efficiency and broad tolerance for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN116813544B reveals catalyst-free heating method for quinoline. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing.